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Saudi Journal of Ophthalmology (2013) 27, 61–63Case ReportPrimary bilateral small lymphocytic lymphoma of ocular adnexal
origin: Imprint cytology suggests the intraoperative diagnosisArghya Bandyopadhyay, MD a,⇑,1; Kaushik Majumdar, MD, DNB a; Mimi Gangopadhyay, MD a; Kalyan Khan, MD a;
Subrata Chakraborty, MD a; Asim Kr. Ghosh, MS bAbstractOcular adnexal lymphomas (OAL) involve the peri-global soft tissues like orbit, eyelid, conjunctiva, lacrimal gland. We describe a
rare case of primary bilateral OAL, histomorphologically small lymphocytic lymphoma, B cell phenotype of lacrimal gland origin.
Rapid intraoperative diagnosis can be suggested on imprint cytology; subsequent histology and immunohistochemistry are helpful
for confirmation and further line of management. Since no preformed lymphoid structures are expected within the orbit or lacrimal
gland, any lymphoid mass here should be critically evaluated as a lymphoproliferative lesion.
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The term ocular adnexal lymphoma (OAL) is used to des-
ignate lymphomas affecting the orbit, eyelid, conjunctiva
and other ocular adnexal structures singly or in combination.
It is estimated to account for nearly 2% of all Non-Hodgkin’s
lymphomas (NHLs) and about 5–15% of NHLs at extra nodal
site.2 Despite this, orbital lymphoma is the most frequent pri-
mary malignant orbital tumor of adults accounting for about
55% of all orbital tumors.5 It affects primarily the orbit (44%),
lacrimal gland (26%), conjunctiva (21%) and eye lid (9%).7 In
about 19% cases of primary orbital NHL there is bilateral lac-
rimal gland involvement.7 Herein we describe a case of pri-
mary bilateral small lymphocytic lymphoma of lacrimal
gland, which had been initially suggested on imprint
cytology.Peer review under responsibility
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A 55-year old lady presented with complaints of gradually
enlarging fullness of bilateral upper eyelids, especially in the
lateral aspects. The swelling of right eyelid was present for
one and half years, while that of left eyelid developed subse-
quently (Fig. 1, above). As a result she developed bilateral
pseudoptosis, more marked in the right. Ocular movement
was slightly restricted in lateral gaze of each eye tested sep-
arately. No diplopia was present; intraocular tension and fun-
dus were unremarkable. Visual acuities with her most recent
correction were 6/6 for both eyes. On palpation, both the
masses were nodular, nontender, freely mobile and rubbery
in consistency. CT scan revealed bilateral enhancing lacrimal
gland mass present behind both eyeballs (mass in the right
side measuring 30  20 mm and that in left 22  11 mm),Production and hosting by Elsevier
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Figure 3. Low magnification photomicrograph showing multinodular
architecture of lacrimal gland replaced by fairly monomorphic population
of lymphoid cells (H & E stain, 40); inset: higher magnification showing
monotonous diffuse proliferation of small lymphoid cells (H & E stain,
400).
Figure 4. CD 20 immunostain showing membranous positivity in the
lymphoid cells (400).
Figure 1. Above: Bilateral swelling of upper eye lids, lateral aspect,
below: Computed tomography shows space occupying lesion behind
both eye balls involving bilateral lateral recti.
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Biopsy from the mass in the right side measured 2 cm in
diameter, with multinodular, soft, gray white, fish flesh in
appearance. The blood mixed fluid adhered to the specimen
was soaked in a filter paper, and imprint cytology smears
were made by touching freshly cut surface of the specimen
on clean, grease free slides. The stained smears showed a
fairly monomorphic population of lymphoid cells, almost
equal to or slightly larger than a mature lymphocyte, with
scanty blue cytoplasm, predominantly condensed chromatin
and inconspicuous nucleoli (Fig. 2). Background showed
few lymphoglandular bodies. A cytologic impression of low
grade (small lymphocytic) lymphoma, along with a differential
diagnosis of atypical lymphoid hyperplasia (ALH) was consid-
ered. Histological examination revealed lymphoid cells ar-
ranged in multinodular pattern replacing the orbital fat
(Fig. 3), bearing similar morphology as seen in cytology
smears (Fig. 3, inset). Immunohistochemistry for CD 20
showed membranous positivity (Fig. 4), while CD 3 was neg-
ative. The diagnosis of extranodal B-cell small lymphocytic
lymphoma was offered. A thorough work up of the patient
was done including complete clinical examination, peripheral
blood film, bone marrow, chest X-ray, CT scan thorax and CT
scan of abdomen, all of which did not reveal any other massFigure 2. Imprint smear of the biopsy material showing lymphoid cells
with scanty blue cytoplasm, slightly opened up chromatin, inconspicuous
nucleoli, and occasional nuclear cleaving (Giemsa stain, 400).lesion or secondary involvement. This patient was also euthy-
roid, and auto-antibodies against extractable nuclear and
cytoplasmic antigen (Ro/SS-A,La/SS-B), Rheumatoid factor
(RF) and anti-nuclear antibody (ANA) were all negative. Ser-
um angiotensin converting enzyme (ACE) was also within
the normal range. As no systemic disease was found, the pa-
tient was treated with local orbital external beam radiother-
apy with shielding of the eyeballs. Periodic follow up with
repeated workup every 6 months interval was recommended.
The patient was doing well during her first two follow up
visits.
Discussion
The lymphoid lesions of orbital region have been de-
scribed under various terms such as chronic nonspecific
inflammation (inflammatory pseudotumor), reactive lymphoid
hyperplasia (pseudolymphoma), atypical lymphoid hyperpla-
sia (ALH), indeterminate cases and lymphoma.1 Many ocular
adnexal neoplasms previously classified as ‘‘pseudolym-
phoma’’ or benign lymphoid hyperplasia may actually contain
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It is to be borne in mind that there are no preformed lymph
nodes within the orbit or within lacrimal gland, therefore any
lymphoid mass within orbit is abnormal.4
As in our case, orbital lymphoma is more common in wo-
men and most of them develop in 5th to 6th decade.4 Bilat-
eral orbital lymphoma develops in about 20% patients and
shows the same morphological, immunological and immuno-
globin gene rearrangement in each eye suggesting origin
from the same clone. As there is no lymphatic connection be-
tween the orbits this could be due to site specific homing.7
The presence of a preexisting inflammatory background
due to infection or autoimmune reaction may have an etio-
pathogenetic role in orbital lymphoma.
Some of the orbital lymphoma patients, especially those
having MALT lymphoma type may have history of autoim-
mune disorders like thyrotoxicosis, sarcoidosis or Sjogren
syndrome.6 However, extensive workup for this patient,
including anti Ro/SS-A, La/SS-B, RF, ANA and ACE did not
reveal any systemic illness or other mass lesion.
On cytology, it may be difficult to distinguish low grade
NHL from ALH or indeterminate lymphocytic lesion.1 In this
case described, initial suggestion of a low grade NHL was of-
fered through imprint cytology of the biopsy material. Subse-
quent histopathology confirmed the diagnosis. The
commonest subtype of lymphoma originating in orbit is extra
nodal marginal zone lymphoma; other low grade lymphomas
which may arise in orbit are small B lymphocytic lymphoma,
follicular lymphoma and rarely mantle cell lymphoma.7 In this
case there was monomorphic nodular and diffuse prolifera-
tion of small lymphocytes consistent with small lymphocytic
lymphoma, with immunohistochemical evidence of clonal B
cell origin (CD 20 positive).
As the patient had primary bilateral orbital lymphoma with
no systemic involvement, we preferred orbital radiotherapy,
which is viewed as the gold standard for primary extranodal
lymphoma localized to the orbit. Other treatment strategies
for OAL are ‘‘wait and watch’’ strategy after surgical resec-
tion or biopsy in patient with stage I disease, chemotherapy
and immunotherapy.3 The role of chemotherapy has not yet
been clearly defined and its role in the treatment of low
grade localized disease is questionable.8 Rituximab is themonoclonal antibody most commonly used for the treatment
of CD 20 positive small lymphocytic lymphoma, and it can be
used to obtain transient symptomatic benefit in OAL patients
for whom other therapeutic strategies are contraindicated.3
Recent experiments do suggest that radioimmunotherapy
with standard doses of 90Y ibritumomab tiuxetan is a safe
and effective front line treatment for early stage extranodal
indolent lymphoma of ocular adnexa.3 The major prognostic
criteria for OAL include anatomic location, stage of disease at
first presentation, lymphoma subtype, immunohistochemical
markers for tumor growth rate and serum lactate dehydroge-
nase (LDH) level.8
To conclude, any lymphoid tissue in the orbital region is
abnormal and should be evaluated with a suspicion of a lym-
phoproliferative lesion. Primary orbital NHL/OAL though
rare, should come in differential diagnosis of bilateral orbital
masses. Rapid intraoperative diagnosis can be suggested by
imprint cytology; histology and immunohistochemistry are
useful for confirmation. Orbital radiotherapy is the treatment
of choice for localized disease, with increasing role of tar-
geted immunotherapy in years to come.
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